Annual Congress Stockholm 2007

Saturday, 15.09.2007
Sunday, 16.09.2007
Monday, 17.09.2007
Tuesday, 18.09.2007
Wednesday, 19.09.2007

Citations should be made in the following way: Authors. Title. Eur Respir J 2007; 30: Suppl. 51, abstract number.

Material from 2007:

4066 Abstracts
635 Slide presentations
310 Webcasts
98 Handouts
1992 e-posters
310 Multimedia files

Material from 2007: Show

Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment

Symposium
Chairs: P. Levy (Grenoble, France), P. Lavie (Haifa, Israel)
Aims: This symposium will:
• identify early changes in cardiovascular function;
• identify early changes in metabolic function in the presence or absence of obesity;
• describe the major signalling pathways involved in inflammation and oxidative stress;
• evaluate the clinical value of biomarkers in the cardiovascular and metabolic fields;
• review possible therapeutic insights.

Download all media

Early changes in blood pressure, vascular and heart function in obstructive sleep apnoea (OSA). Impact of treatment J-L. Pepin (Grenoble, France)
Impact of obstructive sleep apnoea (OSA) on glucose metabolism I. Harsch (Erlangen, Germany)
Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA) S. Ryan (Dublin, Ireland)